• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AG BC GLOBAL WING; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AG BC GLOBAL WING; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 382934
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 08/29/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that bd insyte ag bc global wing catheter broke.The following information was provided by the initial reporter: we recently encountered a critical issue with one of your products, specifically the pink cannula used for blood control.During a surgical procedure, it was observed that the cannula had broken off inside the patient¿s body.A subsequent ct scan confirmed the presence of the cannula fragment inside the patient.This necessitated an additional surgery to remove the broken piece.
 
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Additional Manufacturer Narrative
Investigation results: the complaint of a break in the catheter was confirmed; however, the root cause could not be determined from the three photographs or three 20g insyte autoguard iv catheters that were provided for investigation.The returned samples resembled the 20g insyte autoguard iv catheters that were shown in the photos.One catheter was received in two segments.The features of the adjoining ends of the catheter tubing suggest that needle puncture damage may have been a potential contributing factor of the catheter break; however the root cause could not be determined.As the device had been opened and exhibited evidence of use, it could not be determined with certainty whether the damage originated during manufacturing or use of the device.A review of the inspection records and quality/manufacturing controls for the implicated lot indicated no issues with the manufacturing process.No other similar complaints were reported from the lot.The complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.The unused 20g insyte autoguard device was received with the needle fully retracted.As the device was received in a sealed unit package, the premature retraction likely occurred during assembly.The appropriate manufacturing personnel were notified of this issue, which was unrelated to the reported catheter break.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation results: the complaint of a break in the catheter was confirmed; however, the root cause could not be determined from the photographs that were provided for investigation.The photos showed two 20g insyte autoguard iv catheters with different lengths.Compared with the other iv catheter, one catheter extended only a short distance from the catheter adapter.As the device had been opened and exhibited evidence of use, it could not be determined with certainty whether the damage originated during manufacturing or use of the device.There were no distinguishing features in the photograph which could aid in identification of a specific root cause.A review of the inspection records and quality/manufacturing controls for the implicated lot indicated no issues with the manufacturing process.The complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE AG BC GLOBAL WING
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key20273390
Report Number1710034-2024-01040
Device Sequence Number3505363
Product Code FOZ
UDI-Device Identifier00382903829347
UDI-Public(01)00382903829347
Combination Product (Y/N)N
Initial Reporter CountrySA
PMA/510(K) Number
UNK
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number382934
Device Lot Number4012508
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/29/2024
Supplement Date Received by Manufacturer10/02/2024
11/15/2024
Initial Report FDA Received Date09/20/2024
Supplement Report FDA Received Date10/02/2024
11/18/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-